oseni
Generic: alogliptin and pioglitazone
Labeler: takeda pharmaceuticals america, inc.Drug Facts
Product Profile
Brand Name
oseni
Generic Name
alogliptin and pioglitazone
Labeler
takeda pharmaceuticals america, inc.
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
alogliptin benzoate 25 mg/1, pioglitazone hydrochloride 30 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
64764-253
Product ID
64764-253_2346b7f5-b2c1-45f0-9f8f-5cbb4b202857
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA022426
Listing Expiration
2026-12-31
Marketing Start
2013-01-25
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
64764253
Hyphenated Format
64764-253
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
oseni (source: ndc)
Generic Name
alogliptin and pioglitazone (source: ndc)
Application Number
NDA022426 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 25 mg/1
- 30 mg/1
Packaging
- 30 TABLET, FILM COATED in 1 BOTTLE (64764-253-03)
- 90 TABLET, FILM COATED in 1 BOTTLE (64764-253-04)
- 500 TABLET, FILM COATED in 1 BOTTLE (64764-253-05)
Packages (3)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2346b7f5-b2c1-45f0-9f8f-5cbb4b202857", "openfda": {"upc": ["0364764251031", "0364764253035", "0364764254032", "0364764123031"], "unii": ["JQT35NPK6C", "EEN99869SC"], "rxcui": ["1368410", "1368416", "1368424", "1368430", "1368431", "1368437", "1368438", "1368444"], "spl_set_id": ["4c619ed9-fe3e-4158-9938-80c6c3493d55"], "manufacturer_name": ["Takeda Pharmaceuticals America, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (64764-253-03)", "package_ndc": "64764-253-03", "marketing_start_date": "20130125"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (64764-253-04)", "package_ndc": "64764-253-04", "marketing_start_date": "20130125"}, {"sample": false, "description": "500 TABLET, FILM COATED in 1 BOTTLE (64764-253-05)", "package_ndc": "64764-253-05", "marketing_start_date": "20130125"}], "brand_name": "OSENI", "product_id": "64764-253_2346b7f5-b2c1-45f0-9f8f-5cbb4b202857", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Dipeptidyl Peptidase 4 Inhibitor [EPC]", "Dipeptidyl Peptidase 4 Inhibitors [MoA]", "Peroxisome Proliferator Receptor alpha Agonist [EPC]", "Peroxisome Proliferator Receptor gamma Agonist [EPC]", "Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]", "Peroxisome Proliferator-activated Receptor gamma Agonists [MoA]", "Thiazolidinedione [EPC]", "Thiazolidinediones [CS]"], "product_ndc": "64764-253", "generic_name": "alogliptin and pioglitazone", "labeler_name": "Takeda Pharmaceuticals America, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "OSENI", "active_ingredients": [{"name": "ALOGLIPTIN BENZOATE", "strength": "25 mg/1"}, {"name": "PIOGLITAZONE HYDROCHLORIDE", "strength": "30 mg/1"}], "application_number": "NDA022426", "marketing_category": "NDA", "marketing_start_date": "20130125", "listing_expiration_date": "20261231"}